 |
8 Cyclopentyl 1,3-dipropylxanthine |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1997-03-24 00:00:00 |
| Sponsor | SciClone Pharmaceuticals, Inc.;901 Mariner's Island Boulevard;San Mateo, California, 94404 |
Related Access Program